Organization Overview
Alternative names
aflibercept (zaltrap) (1 trial)
agomelatine (Valdoxan) (1 trial)
Andrographis paniculata (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
azithromycin (zithromax) (1 trial)
bifidobacterium animalis (1 trial)
budesonide (rhinocort) (1 trial)
capecitabine (xeloda) (10 trials)
carboplatin (paraplatin) (15 trials)
cinacalcet (sensipar) (1 trial)
clarithromycin (biaxin) (1 trial)
clavulanate (Augmentin) (1 trial)
decitabine (dacogen) (1 trial)
desflurane (suprane) (1 trial)
dexmedetomidine (precedex) (7 trials)
docetaxel (taxotere) (19 trials)
doxycycline (vibramycin) (1 trial)
eltrombopag (promacta) (2 trials)
endostatin (endostar) (5 trials)
enterococcus faecium (1 trial)
epirubicin (ellence) (6 trials)
insulin human (humulin) (1 trial)
interferon alpha-2b (Intron-A) (2 trials)
Lactobacillus acidophilus (1 trial)
lapatinib (tykerb) (23 trials)
levothyroxine (Synthroid) (1 trial)
metformin (glucophage) (4 trials)
methylprednisolone (medrol) (2 trials)
minocycline (minocin) (1 trial)
nafamostat (ronastat) (1 trial)
paclitaxel (taxol) (43 trials)
pomalidomide (pomalyst) (1 trial)
rituximab (rituxan) (6 trials)
rocuronium (zemuron) (2 trials)
sevoflurane (ultane) (5 trials)
somatropin (protropin) (1 trial)
streptokinase (streptase) (1 trial)
tenofovir alafenamide (genvoya) (1 trial)
urokinase (kinlytic) (1 trial)
vancomycin (Vancocin) (1 trial)
acetylsalicylic acid (aspirin) (1 trial)
asparaginase (elspar) (1 trial)
azacitidine (vidaza) (1 trial)
azathioprine (imuran) (1 trial)
bendamustine (treanda) (1 trial)
bevacizumab (avastin) (14 trials)
bifidobacterium longum (1 trial)
bortezomib (velcade) (3 trials)
cetuximab (erbitux) (2 trials)
cisplatin (platinol) (32 trials)
cyclophosphamide (cytoxan) (15 trials)
cytarabine (cytosar-u) (3 trials)
cytokine induced killer cells (1 trial)
daratumumab (darzalex) (1 trial)
erlotinib (tarceva) (4 trials)
ethambutol (myambutol) (1 trial)
etoposide (vepesid) (8 trials)
everolimus (zortress) (2 trials)
exemestane (aromasin) (2 trials)
Filgrastim (neupogen) (3 trials)
fluorouracil (efudex) (10 trials)
gemcitabine (gemzar) (20 trials)
goserelin (zoladex) (3 trials)
irinotecan (Camptosar) (8 trials)
isoniazid (nydrazid) (1 trial)
loperamide (imodium) (1 trial)
mercaptopurine (purinethol) (2 trials)
mirtazapine (remeron) (1 trial)
monosialotetrahexosyl ganglioside (3 trials)
moxifloxacin (avelox) (1 trial)
oxaliplatin (eloxatin) (15 trials)
pegaspargase (oncaspar) (2 trials)
pembrolizumab (keytruda) (9 trials)
pemetrexed (alimta) (11 trials)
pertuzumab (perjeta) (2 trials)
piperacillin (pipracil) (1 trial)
prednisone (meticorten) (14 trials)
pyrazinamide (Aldinamide) (1 trial)
sorafenib (nexavar) (2 trials)
tamoxifen (nolvadex) (1 trial)
temozolomide (temodar) (2 trials)
thalidomide (Thalomid) (1 trial)
tigecycline (tygacil) (1 trial)
tocilizumab (actemra) (2 trials)
toremifene (fareston) (1 trial)
tranexamic acid (cyklokapron) (1 trial)
trastuzumab (herceptin) (5 trials)
vincristine (oncovin) (11 trials)
vindesine (Eldisine) (2 trials)
vinorelbine (navelbine) (6 trials)
abiraterone (zytiga) (1 trial)
allogeneic cik cells (1 trial)
alprostadil (prostin) (1 trial)
anastrozole (arimidex) (3 trials)
atezolizumab (Tecentriq) (1 trial)
atorvastatin (lipitor) (1 trial)
autologous cytokine induced killer cells (2 trials)
autologous mesenchymal stem cells (1 trial)
baricitinib (olumiant) (1 trial)
chlorotrianisene (tace) (1 trial)
conbercept (Lumitin) (3 trials)
durvalumab (imfinzi) (3 trials)
efgbemalenograstim alfa (1 trial)
fingolimod (gilenya) (1 trial)
fludarabine (fludara) (2 trials)
fulvestrant (faslodex) (2 trials)
furmonertinib (Ives) (1 trial)
lenvatinib (lenvima) (11 trials)
mirabegron (myrbetriq) (1 trial)
osimertinib (tagrisso) (3 trials)
pemigatinib (Pemazyre) (3 trials)
pittsburgh compound b (1 trial)
propranolol (inderal) (1 trial)
qingre liangkou ningxin fang (1 trial)
recombinant human adenovirus type 5 (1 trial)
regorafenib (stivarga) (6 trials)
ropivacaine (naropin) (5 trials)
ruxolitinib (jakafi) (1 trial)
sitagliptin (januvia) (2 trials)
toripalimab (LOQTORZ) (8 trials)
tremelimumab (Imjudo) (1 trial)
trifluridine (viroptic) (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
aripiprazole (abilify) (1 trial)
autologous tumor infiltrating lymphocytes (1 trial)
cd19/cd20 bispecific car-t cells (1 trial)
exosomes from mesenchymal stem cells (1 trial)
abemaciclib (verzenio) (2 trials)
acetylcysteine (mucomyst) (1 trial)
ambrisentan (letairis) (1 trial)
amisulpride (BARHEMSYS) (1 trial)
bicalutamide (casodex) (2 trials)
clindamycin (cleocin) (1 trial)
cyclosporine (sandimmune) (1 trial)
duloxetine (Cymbalta) (1 trial)
escitalopram (lexapro) (1 trial)
esketamine (spravato) (5 trials)
hydroxyethyl starch (voluven) (1 trial)
inotuzumab ozogamicin (besponsa) (1 trial)
lidocaine (xylocaine) (3 trials)
Adenocarcinoma (Phase 2)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Aneurysm (Phase 4)
Angina Pectoris (Phase 2)
Angina, Stable (Phase 2)
Anxiety Disorders (Phase 1)
Arteriosclerosis (Phase 2)
Arteriosclerosis Obliterans (Phase 2)
Astrocytoma (Phase 3)
Biliary Tract Neoplasms (Phase 3)
Blind Loop Syndrome (Phase 2)
Breast Neoplasms (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma in Situ (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Signet Ring Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Cerebral Infarction (Phase 2)
Cervical Intraepithelial Neoplasia (Phase 2)
Cholangiocarcinoma (Phase 3)
Choroidal Neovascularization (Phase 2)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 2)
Coronary Artery Disease (Phase 2)
Delayed Emergence from Anesthesia (Phase 4)
Dementia (Phase 2)
Depressive Disorder (Phase 1)
Depressive Disorder, Major (Phase 1)
Diabetic Retinopathy (Phase 1)
Disease (Phase 2)
Disease Susceptibility (Phase 3)
Dwarfism, Pituitary (Phase 4)
Embolism (Phase 4)
Endocarditis (Phase 4)
Endocrine System Diseases (Phase 4)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Fatty Liver (Phase 4)
Gallbladder Neoplasms (Phase 3)
Gastritis (Phase 4)
Gastrointestinal Neoplasms (Phase 3)
Genetic Predisposition to Disease (Phase 3)
Glioblastoma (Phase 3)
Glioma (Phase 3)
Head and Neck Neoplasms (Phase 3)
Healthcare-Associated Pneumonia (Phase 3)
Heart Failure (Phase 4)
Hematoma (Phase 2)
Hematoma, Subdural (Phase 2)
Hematoma, Subdural, Chronic (Phase 2)
Hemophilia A (Phase 3)
Hyperparathyroidism (Phase 4)
Hyperparathyroidism, Secondary (Phase 4)
Hypertriglyceridemia (Phase 4)
Hypothyroidism (Phase 4)
Infarction (Phase 2)
Infections (Phase 4)
Inflammation (Phase 3)
Intraabdominal Infections (Phase 3)
Kidney Diseases (Phase 4)
Leukemia (Phase 3)
Leukemia, Large Granular Lymphocytic (Phase 3)
Lung Neoplasms (Phase 3)
Lymphatic Metastasis (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Peripheral (Phase 2)
Metabolic Syndrome (Phase 4)
Metaplasia (Phase 3)
Myelodysplastic Syndromes (Phase 4)
Neoplasm Metastasis (Phase 4)
Neoplasms (Phase 2)
Neovascularization, Pathologic (Phase 2)
Neuromyelitis Optica (Phase 3)
Neurotoxicity Syndromes (Phase 3)
Neutropenia (Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 4)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 3)
Pancreatitis (Phase 4)
Parkinson Disease (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Pneumonia (Phase 4)
Postoperative Complications (Phase 4)
Precancerous Conditions (Phase 2)
Preleukemia (Phase 4)
Prostatic Neoplasms (Phase 3)
Pulmonary Embolism (Phase 4)
Purpura (Phase 2)
Purpura, Thrombocytopenic (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 4)
Recurrence (Phase 3)
Renal Insufficiency, Chronic (Phase 4)
Retinal Diseases (Phase 1)
Retinal Perforations (Phase 1)
Retinal Vein Occlusion (Phase 2)
Sarcoma (Phase 2)
Schizophrenia (Phase 4)
Sepsis (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 4)
Stomatitis (Phase 3)
Stroke (Phase 3)
Syndrome (Phase 4)
Thrombocytopenia (Phase 4)
Thromboembolism (Phase 4)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 3)
Tuberculosis (Phase 3)
Tuberculosis, Pulmonary (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 2)
Uveitis (Phase 4)